Evidence map›Paper›PMID 41981173›Full record

ArticleNaunyn-Schmiedeberg's archives of pharmacology2026

Retraction Note: Protective effect of cerium oxide nanoparticles on cisplatin and oxaliplatin primary toxicities in male albino rats.

Amira Mohamed Abdelhamid, Shireen Sami Mahmoud, Aziza E Abdelrahman, Nelly Mohamed Said, Mostafa Toam, Walaa Samy, Marwa AbdEl-Moniem Amer

Abstract readRetraction Notice
PubMed Publisher
In one paragraph

Article in Naunyn-Schmiedeberg's archives of pharmacology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors.

Amira Mohamed AbdelhamidClinical Pharmacology Department, Faculty of Medicine, Zagazig University, Zagazig, Sharqia, Egypt. dr_mero_1985@yahoo.com.ORCID http://orcid.org/0000-0002-0880-3137
Shireen Sami MahmoudClinical Pharmacology Department, Faculty of Medicine, Zagazig University, Zagazig, Sharqia, Egypt.ORCID http://orcid.org/0000-0001-6592-9708
Aziza E AbdelrahmanPathology Department, Faculty of Medicine, Zagazig University, Zagazig, Egypt.ORCID http://orcid.org/0000-0003-4074-4779
Nelly Mohamed SaidPathology Department, Faculty of Medicine, Zagazig University, Zagazig, Egypt.ORCID http://orcid.org/0000-0002-4600-3691
Mostafa ToamClinical Oncology Department, Faculty of Medicine, Zagazig University, Zagazig, Egypt.ORCID http://orcid.org/0000-0002-7979-0791
Walaa SamyBiochemistry Department, Faculty of Medicine, Zagazig University, Zagazig, Egypt.ORCID http://orcid.org/0000-0002-1542-1727
Marwa AbdEl-Moniem AmerForensic Medicine and Clinical Toxicology Department, Faculty of Medicine, Zagazig University, Zagazig, Egypt.ORCID http://orcid.org/0000-0002-3663-262X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID41981173

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.